FdaApplication
NDA 022224
Identifiers
- fda_app_no: NDA022224
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2008-12-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRILIPIX | CHOLINE FENOFIBRATE | EQ 45MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED RELEASE;ORAL |
| TRILIPIX | CHOLINE FENOFIBRATE | EQ 135MG FENOFIBRIC ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED RELEASE;ORAL |
2 products